Morgan Stanley Nephros Inc Put Options Transaction History
Morgan Stanley
- $1.49 Trillion
- Q2 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding NEPH
# of Institutions
22Shares Held
4.37MCall Options Held
0Put Options Held
0-
Wexford Capital LP Greenwich, CT3.61MShares$17.5 Million4.76% of portfolio
-
Vanguard Group Inc Valley Forge, PA323KShares$1.57 Million0.0% of portfolio
-
Bard Associates Inc Chicago, IL131KShares$635,9360.2% of portfolio
-
Geode Capital Management, LLC Boston, MA93.2KShares$451,9560.0% of portfolio
-
High Tower Advisors, LLC Chicago, IL55.9KShares$270,9980.0% of portfolio
About NEPHROS INC
- Ticker NEPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 10,318,800
- Market Cap $50M
- Description
- Nephros, Inc. develops and sells high performance water solutions to the medical and commercial markets in the United States. The company operates in three segments: Water Filtration, Pathogen Detection, and Renal Products. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water ...